Gitnux/Report 2026

Medical Instruments Industry Statistics

The global medical device industry reached approximately $539.8 billion in 2025, explore the figures behind growth, company financials and regulatory trends.
36Statistics
28Sources
5Sections
1Visuals
17mRead
How this report is researched
01Editorial Scope

Before any source is gathered, an editor locks the question, what qualifies, and how the piece will be judged.

02Source Research

Search agents collect the source set and pull each data point out with its provenance attached.

Read our full methodology →

Search agents attach provenance to every extracted figure.

Next review: within 32 days

01 Industry overview

The medical instruments industry at a glance

The global medical device industry reached approximately $539.8 billion in 2025 and is projected to grow at a 5.9% CAGR through 2030, supported by aging populations, digital health and AI-enabled diagnostics.

$539.8B[10]
Global market size, 2025
5.9%[1]
Forecast CAGR to 2030
35.2%[2]
North America share, 2025
29,178[4]
FDA-registered establishments, FY 2025
Market size
The global medical device market was estimated at $539.8 billion in 2025. A separate Frost & Sullivan-based industry analysis reported global medical device revenue of RMB941.7 billion for China in 2024 and described global growth from 2019 to 2024 at an 8.6% CAGR.[10][1]
Forecast & CAGR
The global market is projected to reach $717.4 billion by 2030 at a 5.9% CAGR. In China, the medical device market is projected to reach RMB1,326.0 billion by 2030, also based on a 5.9% CAGR from the 2024 base.[10][1]
Market share & regions
North America held 35.2% of the global medical device market in 2025, followed by Europe at 26.2% and Asia-Pacific at 23.0%. A separate 2024 revenue breakdown placed the United States at $265.7 billion, Europe at $164.5 billion and China at $131.0 billion.[2][1]
Segmentation
Cardiovascular devices were the largest reported product segment in 2025, with a 12.5% share, followed by diagnostic imaging at 10.2%, orthopedics at 9.6%, ophthalmology at 8.4%, drug-delivery devices at 6.9% and endoscopy devices at 6.3%. The industry is also commonly segmented by diagnostic, therapeutic, surgical, monitoring and home-care applications.[2][1]
Key players & concentration
The five largest national markets accounted for approximately 60% of worldwide medical device revenue in 2024, with the United States, China, Germany, Japan and the United Kingdom leading by revenue. At the segment level, General Electric and Siemens Healthineers together held close to three-fifths of global diagnostic-imaging revenue in the cited 2025 market model.[11][12]
Pricing
Publicly comparable industry-wide prices are not available because medical instruments range from low-cost consumables to capital-intensive imaging and surgical systems, and realized prices depend on reimbursement, procurement contracts and service arrangements. As a market indicator, U.S. retail spending on other non-durable medical products, including medical instruments and surgical dressings, rose 4.4% to $128.7 billion in 2024.[13]
Trends, drivers & challenges
Growth is being supported by aging populations, preventive care, home care, digitalization and AI-enabled technologies. The FDA reported more than 1,600 AI-enabled medical devices authorized for U.S. marketing as of September 2026, while industry analysis identified procurement slowdowns, tighter regulation and reimbursement pressure as constraints in some markets.[4][1]
Consumer behavior & competition
Demand is shifting toward preventive monitoring, outpatient care and home care: home care represented 21.0% of China’s medical device market in 2024 and is projected to grow at a 7.9% CAGR through 2030. Competition combines large diversified manufacturers with specialist firms and contract manufacturers, while AI, minimally invasive procedures and connected monitoring are increasing product differentiation.[1][4]
M&A
Medical technology M&A remained active in 2026: KKR agreed to acquire Integer Holdings, a medical-device contract development and manufacturing organization, for an enterprise value of approximately $5.7 billion. Other 2026 transactions cited in industry tracking included Enovis’s planned €155 million acquisition of eCential Robotics and iRhythm’s $287.5 million acquisition of VitalConnect.[14][15]
Regulation
In the United States, medical devices, including AI-enabled devices, are reviewed through risk-based pathways such as 510(k), De Novo classification and premarket approval. The FDA reported 29,178 registered medical device establishments in fiscal 2025, including 13,328 domestic and 15,850 foreign establishments; in the European Union, MDR transitional provisions were amended by Regulation (EU) 2023/607.[4][16]
Latest news
The most significant recent transaction reported for the sector was KKR’s proposed $5.7 billion acquisition of Integer Holdings, announced in August 2026 and cleared for early termination of the U.S. antitrust waiting period in September 2026. Technology development also remains prominent: the FDA’s September 2026 update stated that more than 1,600 AI-enabled medical devices had been authorized for U.S. marketing.[14][4]

02 Ranking

Top 10 Companies in the Medical Instruments Industry

The leading companies in the medical instruments industry, ranked on market impact, performance, momentum, innovation and brand popularity.

Updated November 21, 2026 · Next review December 21, 2026

Verdict

Boston Scientific stands out for minimally invasive cardiovascular and MedSurg device technologies because it reports an 18% operating margin in 2025, while Medtronic focuses on cardiac devices, surgical robotics and insulin pumps since it recorded a 17.8% operating margin in 2025.

Ranked by Overall score · How we score ↓

Editor's top 3 picks

Where to start, by need.

  1. #1 Overall · Leader in minimally invasive therapy

    Boston Scientific

    US

    Ranked #1 · 9.4 · Minimally invasive therapy

    Why we picked it: It concentrates on minimally invasive cardiovascular and MedSurg technologies, with an 18% operating margin in 2025.

  2. Leader in cardiac & diabetes devices

    Medtronic

    IE

    Ranked #2 · 9.1 · Cardiac & diabetes devices

    Why we picked it: It spans cardiovascular devices, surgical robotics and insulin pumps, supported by a 17.8% operating margin in 2025.

  3. Leader in imaging & diagnostics

    Siemens Healthineers

    DE

    Ranked #3 · 9.1 · Imaging & diagnostics

    Why we picked it: It focuses on imaging, diagnostics and minimally invasive therapy, reporting a 16.5% operating margin in 2025.

Pick 1 is the #1 company overall. Picks 2 and 3 are the highest-ranked companies in the top 5 that add a new segment.

Full ranking

Sort by
Top 10 companies in the medical instruments industry, 2026 – Gitnux ranking
#CompanyOverall ↓Company snapshot
1

Boston Scientific

Minimally invasive therapy · US

9.4
2

Medtronic

Cardiac & diabetes devices · IE

9.1
3

Siemens Healthineers

Imaging & diagnostics · DE

9.1
4

Johnson & Johnson

Surgical & vision devices · US

9.0
5

Stryker

Orthopaedics & neurovascular · US

9.0
6

GE HealthCare

Imaging, patient care and pharmaceutical diagnostics · US

8.7
7

Olympus

Endoscopy and minimally invasive surgical devices · JP

8.6
8

BD

Injection, medication management and diagnostic devices · US

8.4
9

Zimmer Biomet

Orthopaedic implants and surgical technologies · US

8.3
10

ResMed

Sleep-apnoea and respiratory medical devices · US

8.2

How we score

  • Impact (30%): scale and weight in the market (revenue, market share, employees, market position).
  • Performance (20%): recent revenue growth and operating margin; an analyst assessment where a company does not publish them.
  • Momentum (20%): growth trajectory and future potential.
  • Innovation (15%): R&D intensity and how technologically advanced the company is.

Popularity (brand search demand, 15%) counts toward Overall but is not published as a column. Overall leaves out what is not known.

Scale Scores are shown on a 7–10 scale with one decimal; bars start at 7.0.

Cadence Recalculated when new figures are published; next review December 21, 2026.

Independence. Rankings are editorially independent. Scores, ranks, picks and the verdict follow the method above; no company can pay to change them.

Cite this ranking

APA

Samuel Norberg. (2026, November 21). Top 10 companies in the medical instruments industry. In Medical Instruments Industry Statistics. Gitnux. https://gitnux.org/medical-instruments-industry-statistics/#top-companies

report visual · Comparison

Global medical device market size

Global medical device market size: $518.0B in 2024, $518.0B in 2024.

2029 (forecast)$667.4B
2028 (forecast)$634.4B
2027 (forecast)$603.1B
2026 (forecast)$573.3B
2025 (forecast)$544.9B
2024$518.0B
source-verifiedsebi.gov.in2029

04 Statistics

Market Intelligence

Market sizing and regional splits anchor the demand picture. North America accounts for about 35.2% of the global medical-device market in 2025.

Market size, volume and shipments in the medical instruments industry

  • US$623.0 billion was the 2024 global medical-device market, covering medical equipment and consumables across clinical applications; Frost & Sullivan estimate cited in a 2026 filing.[1]
  • US$518.0 billion was the 2024 global medical-device market, according to a Frost & Sullivan estimate using the medical-device market category.[2]

Forecast growth and shipments in the medical instruments industry

  • The global medical-device market is projected to reach US$1,157.6 billion in 2035, with 5.7% CAGR for 2031–2035; the category covers medical equipment and consumables.[1]
  • The global medical-device market is projected to reach US$729.8 billion in 2030, implying 6.2% CAGR for 2025–2030 under this estimate.[2]
  • The global medical-device market is projected to reach US$869.7 billion in 2030, with 6.0% CAGR for 2025–2030; the category covers medical equipment and consumables.[1]

Company counts and size structure in the medical instruments industry

  • 8,825 employer establishments operated in US medical equipment and supplies manufacturing in 2023, classified under NAICS 3391.[3]
  • 6,553 registered medical-device establishments were located in China in fiscal year 2025, the largest listed foreign-region count in the FDA report.[4]
  • 29,178 medical-device establishments registered with FDA in fiscal year 2025: 13,328 domestic and 15,850 foreign establishments.[4]

Regional split of the medical instruments industry

  • North America accounted for about 35.2% of the global medical-device market, valued at approximately US$190.2 billion in 2025.[2]
  • Latin America accounted for about 8.8% of the global medical-device market, valued at approximately US$47.5 billion in 2025.[2]
  • Middle East and Africa accounted for about 6.8% of the global medical-device market, valued at approximately US$36.7 billion in 2025.[2]
  • Asia-Pacific accounted for about 23.0% of the global medical-device market, valued at approximately US$124.3 billion in 2025.[2]

05 Statistics

Product & Standards

Quality certification coverage helps track operational readiness. At 31 December 2024, 43,957 sites held ISO 13485:2016 certificates worldwide.

Standards, grades and specs for medical instruments

  • 43,957 sites were covered by ISO 13485:2016 certificates worldwide at 31 December 2024.[5]
  • 31,215 valid ISO 13485:2016 certificates covered medical-device quality-management systems worldwide at 31 December 2024.[5]
  • 4,595 ISO 13485 certifications were reported for China in 2024, the highest country count in the ISO Survey table.[6]

06 Statistics

People & Workforce

Workforce staffing figures quantify operational scale in medical equipment and supplies manufacturing. U.S. employment reached 325,800 in 2025 under NAICS 339100.

Employment and hiring in the medical instruments industry

  • 48,060 miscellaneous assemblers and fabricators were employed in U.S. medical equipment and supplies manufacturing in May 2024.[7]
  • 13,840 industrial engineers were employed in U.S. medical equipment and supplies manufacturing in May 2024.[7]
  • 14,070 inspectors, testers, sorters, samplers and weighers were employed in U.S. medical equipment and supplies manufacturing in May 2024.[7]
  • 325,800 employees worked in U.S. medical equipment and supplies manufacturing in 2025, classified under NAICS 339100; employment is projected to reach 335,800 in 2035.[7]

Workplace safety in the medical instruments industry

  • 1.2 other recordable occupational injury and illness cases occurred per 100 full-time-equivalent workers in U.S. surgical and medical instrument manufacturing in 2024.[7]
  • 0.4 cases involving days away from work occurred per 100 full-time-equivalent workers in U.S. surgical and medical instrument manufacturing in 2024.[7]
  • 1.1 cases involving days away from work, job transfer or restriction occurred per 100 full-time-equivalent workers in U.S. surgical and medical instrument manufacturing in 2024.[7]
  • 0.7 cases involving job transfer or restriction occurred per 100 full-time-equivalent workers in U.S. surgical and medical instrument manufacturing in 2024.[7]

07 Statistics

Pricing & Finance

Producer price indexes provide an industry-wide cost signal for medical instruments. The U.S. surgical and medical instruments PPI was 155.359 in December 2025.

Prices and price indices for medical instruments

  • 118.282 was the December 2025 producer price index for U.S. other surgical and medical apparatus and instruments excluding parts, product code 339112-06, on a June 2012=100 basis; it was 110.856 in December 2024.[7]
  • 155.359 was the December 2025 producer price index for U.S. surgical and medical instruments, NAICS 339112 product code 339112-0, on a June 1982=100 basis; it increased from 146.111 in November 2023.[7]
  • 118.231 was the December 2025 producer price index for U.S. surgical and orthopedic instruments, product code 339112-01, on a June 2012=100 basis; it was 118.102 in December 2024.[7]
  • 124.567 was the December 2025 producer price index for U.S. surgical and medical catheters, product code 339112-05, on a June 1982=100 basis; it was 122.516 in December 2024.[7]

08 Statistics

Regulation & Risk

Regulatory and safety metrics show risk cadence. U.S. medical-device recalls recorded totaled 1,017 in fiscal 2024.

Regulations and compliance for medical instruments

  • $636,732 is the FY2027 standard FDA fee for a PMA, PDP, PMR or applicable BLA submission for medical devices, effective October 1, 2026, through September 30, 2027.[4]
  • 31 December 2027 is the EU transition deadline for certain Class III and implantable Class IIb medical devices under Regulation (EU) 2023/607, subject to stated conditions.[8]
  • $13,785 is the FY2027 annual establishment-registration fee for most U.S. medical-device establishments under FDA MDUFA, effective October 1, 2026, through September 30, 2027.[4]
  • 31 December 2028 is the EU transition deadline for certain Class IIb, Class IIa and specified Class I medical devices under Regulation (EU) 2023/607, subject to stated conditions.[8]
  • $28,653 is the FY2027 standard FDA fee for a 510(k) premarket notification for medical devices, effective October 1, 2026, through September 30, 2027.[4]

Recalls and safety notices for medical instruments

  • 1,017 medical-device recalls were recorded in U.S. fiscal year 2024, according to FDA recall data analyzed by the Government Accountability Office.[9]
  • 125 safety-related communications were issued by FDA CDRH in 2025 as part of its medical-device oversight activities.[4]
  • 1,048 medical-device recall summaries were issued by FDA’s CDRH in 2024.[4]
  • 51 device safety-related communications were issued by FDA during 2023–2024, comprising 27 medical-device safety communications, 23 letters to health-care providers and 1 biologics communication.[4]

Key questions about the medical instruments industry

What is the medical instruments market size?
The global medical device industry reached approximately $539.8 billion in 2025.
How fast does the market grow through 2030?
The global medical device market is projected to grow at a 5.9% CAGR through 2030, reaching $717.4 billion by 2030.
Which companies lead the medical instruments industry?
Boston Scientific stands out for minimally invasive cardiovascular and MedSurg device technologies because it reports an 18% operating margin in 2025, while Medtronic focuses on cardiac devices, surgical robotics and insulin pumps since it recorded a 17.8% operating margin in 2025.
What technology shifts are showing up in regulatory activity?
The FDA reported more than 1,600 AI-enabled medical devices authorized for U.S. marketing as of September 2026.
How is the industry structured across regions?
North America held 35.2% of the global medical device market in 2025, followed by Europe at 26.2% and Asia-Pacific at 23.0%.
What does the regulatory base look like in the U.S.?
The FDA reported 29,178 registered medical device establishments in fiscal 2025, with 13,328 domestic and 15,850 foreign establishments.
Reference

Cite This Report

This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.

APA
Samuel Norberg. (2026, November 21). Medical Instruments Industry Statistics. Gitnux. https://gitnux.org/medical-instruments-industry-statistics
MLA
Samuel Norberg. "Medical Instruments Industry Statistics." Gitnux, 21 Nov 2026, https://gitnux.org/medical-instruments-industry-statistics.
Chicago
Samuel Norberg. 2026. "Medical Instruments Industry Statistics." Gitnux. https://gitnux.org/medical-instruments-industry-statistics.